University of Patras
Μελέτη του βασικού μεταβολισμού, της αντίστασης στην ινσουλίνη και των πολυμορφισμών των α2Β και β3 αδρενεργικών υποδοχέων, του γονιδίου του υποδοχέα της ινσουλίνης, του PPARγ γονιδίου και του γονιδίου του HSD17B5 σε Ελληνίδες με σύνδρομο των πολυκυστικών ωοθηκών
Abstract
dc:descriptionPolycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-age women, affecting 6%–10% of the population and is the leading cause of anovulatory infertility in women. It is characterized by hirsutism, anovulation, and hyperandrogenemia and is highly associated with obesity and insulin resistance (IR). The aim of our study was to investigate, whether polymorphisms of genes associated with certain characteristics of PCOS were linked with various clinical parameters of PCOS, such as hyperandogenemia, basic metabolic rate (BMR) and insulin resistance. The candidate genes chosen for this study were the α2Β, β3 adrenergic receptor gene, 17b-Hydroxysteroid dehydrogenase type 5 gene, the IRS-1 gene, and the PPARγ gene. The α2Β, β3 adrenergic receptor gene polymorphisms were associated with low basal metabolic rate and weight gain in previous studies. As obesity is a characteristic of PCOS women, we investigated whether α2Β adrenergic receptor polymorphism is present in PCOS. 17b-Hydroxysteroid dehydrogenase type 5 (HSD17B5) is the enzyme responsible for reduction of androstenedione to testosterone. IRS-1 has an important role in regulating the cellular effect of insulin. (Gly972Arg refSNP ID: rs1801278) the polymorphism of IRS-1 protein which occurs in about 5-6% of the general population, significantly impairs IRS-1 function and is associated with IR, lipid abnormalities, and type 2 diabetes mellitus. PPARγ gene modulates the expression of many genes involved in glucose and lipid homeostasis. We found that α2Β adrenoreceptor 301–303 deletion polymorphism does not influence basal metabolic rate, insulin resistance or weight gain in women with PCOS and its prevalence did not differ from the general population. HSD17B5 variant was associated with increased serum testosterone levels and decreased androstenedione (A)/testosterone (T) ratio. Diagnosis of PCOS was based on the simultaneous presence of biochemical hyperandrogenism, which was defined as increased serum. Testosterone and/or increased free androgen index, chronic anovulation, and polycystic ovarian morphology on ultrasound. The results of our study confirm an earlier report that the polymorphism can not play a major role in the genetic pathogenesis of PCOS. However, the presence of the polymorphism has a clinical significance as it contributes to the severity of hyperandrogenemia in PCOS patients with biochemical hyperandrogenism. Genotype frequencies of the Pro12Ala in PPARγ2 and the Gly972Arg in IRS-1 gene polymorphisms among PCOS women did not differ from that of the general population, still the presence of Pro12Ala polymorphism of PPARγ2 was associated with lower Basic Metabolic Rate (BMR).
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Saltamavros, Alexandros
- Σαλταμαύρος, Αλέξανδρος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26485